<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111325</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">New oral anticoagulants in the treatment of venous thromboembolic disease</dc:title>
<dc:description xml:lang="en">Rivaroxaban is a direct inhibitor of activated factor X, and dabigatran is a direct inhibitor of thrombin. These new oral anticoagulants have demonstrated to be effective and safe in clinical trials on the treatment of venous thromboembolic disease (deep vein thrombosis and pulmonary thromboembolism) (AU)</dc:description>
<dc:creator>Lima Rodríguez, E. M</dc:creator>
<dc:creator>Calvo Romero, J. M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El rivaroxabán es un inhibidor directo de factor X activado y el dabigatrán un inhibidor directo de la trombina. Estos nuevos anticoagulantes orales han demostrado en ensayos clínicos su eficacia y seguridad en el tratamiento de la enfermedad tromboembólica venosa (trombosis venosa profunda y tromboembolia pulmonar) (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);39(3): 146-149, abr. 2013.</dc:source>
<dc:identifier>ibc-111325</dc:identifier>
<dc:title xml:lang="es">Nuevos anticoagulantes orales en el tratamiento de la enfermedad tromboembólica venosa</dc:title>
<dc:subject>^d23521^s22073</dc:subject>
<dc:subject>^d14308^s22054</dc:subject>
<dc:subject>^d932^s22073</dc:subject>
<dc:subject>^d31485^s22073</dc:subject>
<dc:subject>^d52618^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22173^s22073</dc:subject>
<dc:subject>^d14308^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d52618^s22080</dc:subject>
<dc:subject>^d11756^s22048</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:subject>^d11756^s22066</dc:subject>
<dc:type>article</dc:type>
<dc:date>201304</dc:date>
</metadata>
</record>
</ibecs-document>
